Obsessive-Compulsive Disorder Clinical Trial
Official title:
Zum Umgang Mit Aufdringlichen Gedanken Bei Der Zwangsstörung - Zwei Behandlungsstrategien im Vergleich
The purpose of this study is to assess and compare the overall efficacy and differential effects of detached mindfulness and cognitive restructuring in the treatment of patients with obsessive-compulsive disorder.
The purpose of this study is to assess and compare the overall efficacy and differential
effects of two interventions for patients suffering from obsessive-compulsive disorder (OCD)
according to DSM-5. The interventions to be compared are detached mindfulness (DM) and
cognitive restructuring (CR). Whereas the efficacy of CR for the treatment of OCD has been
proven in various studies, the efficacy of DM as a single intervention so far has only been
shown within a case study and within a non-clinical sample. By contrast, the efficacy of
complex metacognitive protocols (of which DM constitutes one of several single interventions)
has been shown multiple times. So far, however, little is known about the efficacy of DM as a
single intervention in a clinical sample and the differential working mechanisms of DM vs.
CR.
Whereas DM is supposed to modify metacognitions by teaching patients to solely observe their
intrusive thoughts, CR aims at teaching the patients to actively question and modify their
distorted interpretations of their intrusions. Since previous research has shown that symptom
reduction is mediated by a change in metacognition but not by a change of distorted
interpretations, the investigators hypothesize that, while expecting both interventions to be
similarly effective on an overall scale, DM will lead to a change in both metacognitions and
distorted interpretations whereas CR will predominantly have an effect on distorted
interpretations while influencing metacognitions to a lesser extent. Further research
questions address differences concerning the applicability of the two interventions in
patients' everyday life and the degree to which an intense psychoeducation can already have
an effect on the participants' overall symptom burden.
The intervention (both DM and CR) is spread over four sessions of 100 min each taking place
within two weeks (i.e. two sessions per week) and includes intensive homework assignments for
the patients. The intervention will be delivered by MSc-level clinical psychologists
completing the clinical training for becoming a licenced psychotherapist in Germany
("Psychologischer Psychotherapeut"). The diagnostic assessment involves clinical interviews
and a number of questionnaires and will be conducted by independent assessors who have a
qualification similar to the study therapists. Assessment involves pre-, post- and follow-up
assessment. Additionally, assessment comprises data collection via ecological momentary
assessment (EMA) in order to measure OCD symptoms (intrusions, emotions and coping
strategies), the degree to which participants apply the newly learned strategy (DM or CR) in
everyday life and the amount of relief experienced from applying it. There will be one EMA
before (Pre-EMA) and one after the intervention (Post-EMA). For EMA, participants receive a
smartphone for four days each (Friday to Monday) and are randomly prompted ten times per day
to fill in a short questionnaire. The average amount of time necessary to fill in the
questionnaire is assumed to be less than 2 min, based on a sample trial with mentally healthy
participants.
Participants will be randomly assigned to one of three groups: 1) DM, 2) CR, and 3) a
waitlist control group. The waitlist control group will wait for two weeks (i.e., as long as
the intervention in the other two groups last), before participants will be once more
randomly assigned to one of the two active conditions (DM and CR), which they will then
regularly participate in. Thus, all participants enrolled in the study receive one of the two
treatments sooner or later. For participants who are initially assigned to the waitlist
group, there will be a second pre-assessment prior to the start of the intervention.
The study is going to be sponsored by the Christoph-Dornier-Stiftung für Klinische
Psychologie, which is a non-profit organization that supports research in clinical psychology
and awards PhD scholarships to clinical psychologists. The study at hand is the major part of
the PhD project of Christian Rupp, M. Sc., and Charlotte Juergens, M. Sc., who are currently
holding a PhD scholarship by the Christoph-Dornier-Stiftung für Klinische Psychologie. The
Christoph-Dornier-Stiftung für Klinische Psychologie collaborates with Department of Clinical
Psychology at the University of Muenster (Westfälische Wilhelms-Universität). The The PhD
project is being supervised scientifically by Principal Investigator Prof. Dr. Ulrike
Buhlmann, who is a professor of clinical psychology at the University of Muenster
(Westfälische Wilhelms-Universität), Germany.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04934007 -
Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder
|
N/A | |
Recruiting |
NCT04071990 -
Family Involvement in CBGT of OCD: a Randomized Controlled Trial
|
N/A | |
Completed |
NCT02541968 -
Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Recruiting |
NCT05391503 -
Light Therapy for Obsessive-compulsive Disorder (OCD)
|
N/A | |
Recruiting |
NCT04539951 -
Pragmatic Trial of Obsessive-compulsive Disorder
|
Phase 2 | |
Completed |
NCT03416504 -
Methods for Managing Intrusive Thoughts
|
N/A | |
Not yet recruiting |
NCT06029738 -
Effect on Obsessive-Compulsive Beliefs and Symptoms of MCT-OCD
|
N/A | |
Recruiting |
NCT02844049 -
European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS
|
N/A | |
Terminated |
NCT02909660 -
What Are You Looking for? Psychometric and Experimental Analyses of Reassurance Seeking in Obsessive-compulsive Disorder
|
N/A | |
Completed |
NCT02911324 -
Cannabinoid Medication for Adults With OCD
|
Phase 1/Phase 2 | |
Terminated |
NCT02234011 -
A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder
|
Phase 2 | |
Completed |
NCT02217995 -
Mindfulness-Based Cognitive Therapy in a Clinical Sample of OCD Patients
|
N/A | |
Withdrawn |
NCT01953042 -
Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders
|
N/A | |
Completed |
NCT02655926 -
Deep Brain Stimulation for Severe Obsessive Compulsive Disorder
|
N/A | |
Completed |
NCT04919785 -
Deep Brain Stimulation in Severe Obsessive-compulsive Disorder
|
N/A | |
Terminated |
NCT00758966 -
Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder
|
Phase 2 | |
Completed |
NCT00742664 -
Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project
|
Phase 1/Phase 2 | |
Completed |
NCT00523718 -
Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder
|
Phase 2 | |
Completed |
NCT00074815 -
Treatment of Obsessive Compulsive Disorder in Children
|
Phase 3 |